Ultragenyx Pharmaceutical Inc. (RARE)

NASDAQ: RARE · Real-Time Price · USD

26.80

+0.89 (3.43%)

Aug 10, 2026, 4:00 PM EDT - Market closed

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
North America Revenue	396.54M	377.00M	340.46M
Latin America Revenue	175.36M	170.00M	130.71M
Europe Revenue	123.88M	108.00M	80.12M
Asia-Pacific Revenue	21.15M	18.00M	8.93M
Revenue (Other)	279.00K	-	-230.00K
Revenue (Total)	717.21M	673.00M	560.00M

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Crysvita Revenue	187.00M	177.00M	134.71M
Dojolvi Revenue	101.28M	96.00M	88.19M
Evkeeza Revenue	72.72M	59.00M	32.16M
Mepsevii Revenue	37.00M	37.00M	30.35M
Total Product Revenue	397.99M	369.00M	285.42M
Crysvita Royalty Revenue	318.94M	304.00M	274.82M
Revenue (Other)	279.00K	-	-230.00K
Revenue (Total)	717.21M	673.00M	560.00M